MDCalc

ASTRAL Score for Ischemic Stroke

Predicts 90-day poor outcome in patients with acute ischemic stroke.

Use in patients with acute ischemic stroke admitted within 24 hours of stroke onset.

years
points

>3 hrs from symptom onset (or last time seen WITHOUT stroke symptoms) to admission

Any new visual field defect

Admission glucose >131 mg/dL (7.3 mmol/L) or <66 mg/dL (3.7 mmol/L)

Impaired consciousness

Result:

Please fill out required fields.
Advice
  • Acute ischemic stroke is a neurological emergency that is amenable to time-sensitive treatments (e.g. tPA, mechanical thrombectomy) if certain clinical conditions are met.
  • Neurological consultation should be obtained immediately in suspected cases of acute ischemic stroke.
  • Should not be used as a substitute for clinical judgment and is intended for use as an adjunct to medical decision-making.
Management
  • In cases of suspected ischemic stroke, the following is recommended:
    • STAT neurological consultation.
    • STAT CT head without contrast.
    • STAT laboratory testing (complete blood count, PT/INR/aPTT, basic metabolic panel, type & screen, troponin-I).
    • Consider STAT CT angiogram of the head & neck in cases of suspected large-vessel occlusion (LVO) presenting in the acute setting.
Critical Actions
  • Intravenous tissue plasminogen activator (IV tPA) is the standard-of-care treatment for adult patients presenting with acute ischemic stroke within 4.5 hours of symptom onset, if no exclusion criteria are met.
  • Mechanical thrombectomy is the standard-of-care treatment for selected adult patients presenting with acute ischemic stroke due to LVO presenting in the acute setting.
  • Note that the appropriateness of patient for endovascular intervention depends on multiple factors, such as time since onset, neuroimaging, baseline functional status, and others.
  • Appropriateness for intravenous thrombolysis or mechanical thrombectomy should be determined by neurological/neurosurgical consultant whenever available.